Cargando…
Autologous immune enhancement therapy: A case report of a stage IV colonic cancer
Current modalities of cancer treatment, including surgery, chemotherapy and radiotherapy, show marginal therapeutic responses in cancer patients. In adoptive immunotherapy, interleukin-2 (IL-2) activated immune cells demonstrated notable results in patients with advanced malignant disease. The prese...
Autores principales: | SUBRAMANI, BASKAR, RATNAVELU, KANANATHAN, PULLAI, CHITHRA RAMANATHAN, KRISHNAN, KOHILA, SUGADAN, SHEELA DEVI, DENG, XUEWEN, HIROSHI, TERUNUMA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678846/ https://www.ncbi.nlm.nih.gov/pubmed/23761827 http://dx.doi.org/10.3892/ol.2013.1246 |
Ejemplares similares
-
Autologous immune enhancement therapy against an advanced epithelioid sarcoma: A case report
por: RATNAVELU, KANANATHAN, et al.
Publicado: (2013) -
Autologous Immune Enhancement Therapy in Recurrent Ovarian Cancer with Metastases: A Case Report
por: Manjunath, Sadananda Rao, et al.
Publicado: (2012) -
Harnessing NK Cells to Control Metastasis
por: Deng, Xuewen, et al.
Publicado: (2022) -
NK cell-based autologous immune enhancement therapy (AIET) for cancer
por: Terunuma, H, et al.
Publicado: (2013) -
Immunosurveillance of Cancer and Viral Infections with Regard to Alterations of Human NK Cells Originating from Lifestyle and Aging
por: Deng, Xuewen, et al.
Publicado: (2021)